pubmed.ncbi.nlm.nih.gov

Economic Value of Initial Implementation Activities for Proposed Ban on Sales of Over-The-Counter Diet Pills and Muscle-Building Supplements to Minors - PubMed

  • ️Sun Jan 01 2023

Economic Value of Initial Implementation Activities for Proposed Ban on Sales of Over-The-Counter Diet Pills and Muscle-Building Supplements to Minors

Cynthia A Tschampl et al. AJPM Focus. 2023.

Abstract

Introduction: Over-the-counter diet pills, weight-loss supplements, and muscle-building supplements often contain harmful ingredients and are associated with eating disorder diagnoses and other negative health outcomes. This study estimated the value of state initial implementation activities, for example, regulation development, to implement a ban on the sale of dangerous over-the-counter diet pills and muscle-building supplements to minors.

Methods: We enumerated minimum, best, and maximum values for 22 inputs among 11 activities state employees may undertake if the legislation were signed into law. For employment costs, we estimated staff hours on the basis of data from 10 key informants and obtained salary ranges from a state government website. Data were collected and analyzed between September 2021 and January 2022. We calculated 95% CIs using 10,000 Monte Carlo simulations that varied inputs simultaneously and probabilistically. We conducted two sensitivity analyses using all minimum and all maximum salaries.

Results: The estimated value of state start-up activities was $47,536 (95% CI=$36,831-$57,381). Inputs with the largest impact on this estimate corresponded to combinations of the highest salary and greatest hours per task.

Conclusions: The state's one-time opportunity cost to initiate this age-restriction policy would be minimal considering potential health gains. Sensitivity analyses did not change the conclusion, especially if the state produces subregulations linked to existing law rather than new regulations.

Keywords: Eating disorders; economic evaluation; implementation; prevention; state policy; weight-loss supplements.

© 2023 The Authors.

PubMed Disclaimer

Figures

Image, graphical abstract
Graphical abstract
Figure 1
Figure 1

Estimated opportunity costs for implementation activities: Top 10 inputs ranked by effects on output mean.

Similar articles

References

    1. Steffen KJ, Mitchell JE, Le Grange D, et al. A prevalence study and description of alli use by patients with eating disorders. Int J Eat Disord. 2010;43(5):472–479. doi: 10.1002/eat.20829. - DOI - PMC - PubMed
    1. Levinson JA, Sarda V, Sonneville K, Calzo JP, Ambwani S, Austin SB. Diet pill and laxative use for weight control and subsequent incident eating disorder in US young women: 2001–2016. Am J Public Health. 2020;110(1):109–111. doi: 10.2105/AJPH.2019.305390. - DOI - PMC - PubMed
    1. Hazzard VM, Simone M, Austin SB, Larson N, Neumark-Sztainer D. Diet pill and laxative use for weight control predicts first-time receipt of an eating disorder diagnosis within the next 5 years among female adolescents and young adults. Int J Eat Disord. 2021;54(7):1289–1294. doi: 10.1002/eat.23531. - DOI - PMC - PubMed
    1. Cohen PA, Goday A, Swann JP. The return of rainbow diet pills. Am J Public Health. 2012;102(9):1676–1686. doi: 10.2105/AJPH.2012.300655. - DOI - PMC - PubMed
    1. Nagata JM, Hazzard VM, Ganson KT, Austin SB, Neumark-Sztainer D, Eisenberg ME. Muscle-building behaviors from adolescence to emerging adulthood: A prospective cohort study. Prev Med Rep. 2022;27 doi: 10.1016/j.pmedr.2022.101778. - DOI - PMC - PubMed

LinkOut - more resources